Skip to main content
. 2023 Jan 30;12:1065716. doi: 10.3389/fonc.2022.1065716

Table 2.

Multivariate Cox analysis for OS in normal-weight patients.

Variable HR (univariable) HR (multivariable)
Age, y 1.02 (1.01-1.04, p=0.009) 1.03 (1.01-1.05, p=0.001)
Sex Female [Reference] [Reference]
Male 0.92 (0.61-1.37, p=0.668) 0.70 (0.39-1.28, p=0.250)
BMI, kg/m² 0.90 (0.81-1.01, p=0.082) 0.89 (0.77-1.01, p=0.081)
Tobacco Never [Reference] [Reference]
Former 1.28 (0.80-2.06, p=0.306) 1.54 (0.82-2.91, p=0.178)
Current 0.94 (0.57-1.53, p=0.791) 1.31 (0.69-2.46, p=0.408)
Tumor location Lower third [Reference] [Reference]
Middle thrid 1.58 (1.04-2.41, p=0.034) 1.30 (0.83-2.02, p=0.249)
Upper third 1.00 (0.54-1.83, p=0.990) 0.98 (0.52-1.86, p=0.962)
Tumor size, cm 1.19 (1.11-1.28, p<0.001) 1.04 (0.94-1.14, p=0.440)
Tumor grade Poorly differentiated [Reference] [Reference]
Well-moderately differentiated 0.56 (0.35-0.92, p=0.022) 0.72 (0.43-1.22, p=0.226)
TNM Stage I [Reference] [Reference]
II 2.59 (1.20-5.57, p=0.015) 2.61 (1.20-5.67, p=0.016)
III 10.96 (5.63-21.35, p<0.001) 9.03 (4.47-18.25, p<0.001)
IV 23.83 (9.00-63.07, p<0.001) 25.87 (9.19-72.83, p<0.001)
Postoperative complication No [Reference] [Reference]
Yes 1.35 (0.85-2.13, p=0.200) 1.09 (0.64-1.84, p=0.753)
Splenic volume < 215 ml [Reference] [Reference]
≥ 215 ml 1.55 (1.01-2.39, p=0.045) 1.86 (1.15-3.02, p=0.012)
HHS Vulnerability Disclosure